Skip to main content

Table 2 Clinical outcome of relapsing-remitting-EAE mice treated with hAECs

From: Immunosuppressive potential of human amnion epithelial cells in the treatment of experimental autoimmune encephalomyelitis

  1 × 106 hAECs 5 × 106 hAECs PBS
Disease incidence 4/7 3/7 7/7
Day disease onset 17.25 ± 5.3 15.7 ± 2.0 16.7 ± 1.6
Death severe disease 1/7 1/7 3/7
Maximum score 1.9 ± 0.6* 1.3 ± 0.7* 3.8 ± 0.5
Cumulative score 24.9 ± 10.2* 20.8 ± 12.0* 57.3 ± 9.79
  1. *P < 0.05 compared to PBS